atomoxetine hydrochloride has been researched along with Smoking Cessation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jepson, C; Lerman, C; Lynch, K; Patterson, F; Ray, R; Rukstalis, M; Strasser, A | 1 |
| Creeden, C; George, TP; Reutenauer, EL; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| Silva, RR | 1 |
1 trial(s) available for atomoxetine hydrochloride and Smoking Cessation
| Article | Year |
|---|---|
Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Cognition Disorders; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Norepinephrine; Prefrontal Cortex; Propylamines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation | 2009 |
2 other study(ies) available for atomoxetine hydrochloride and Smoking Cessation
| Article | Year |
|---|---|
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Cognition; Cognition Disorders; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Propylamines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2009 |
Two recent updates for psychiatric conditions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atomoxetine Hydrochloride; Benzazepines; Bupropion; Chemical and Drug Induced Liver Injury; Congresses as Topic; Drug Labeling; Humans; Middle Aged; Product Surveillance, Postmarketing; Propylamines; Quinoxalines; Smoking Cessation; Suicide; United States; United States Food and Drug Administration; Varenicline | 2009 |